Evidence map›Paper›PMID 26015329›Full record

ArticleMuscle & nerve2016

Assessment of intensive care unit-acquired weakness in young and old mice: An E. coli septic peritonitis model.

Esther Witteveen, Inge C M Hoogland, Luuk Wieske, Nina C Weber, Camiel Verhamme, Marcus J Schultz, Ivo N van Schaik, Janneke Horn

Open access · hybridAbstract read
In one paragraph

Article in Muscle & nerve, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Muscle weakness in aAnnals of translational medicine · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Esther WitteveenDepartment of Intensive Care Medicine, Academic Medical Center, Room G3-228, PO box 22700, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.
Inge C M HooglandDepartment of Neurology, Academic Medical Center, Amsterdam, the Netherlands.
Luuk WieskeDepartment of Intensive Care Medicine, Academic Medical Center, Room G3-228, PO box 22700, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.
Nina C WeberLaboratory of Experimental Intensive Care and Anesthesiology (L·E·I·C·A), Academic Medical Center, Amsterdam, the Netherlands.
Camiel VerhammeDepartment of Neurology, Academic Medical Center, Amsterdam, the Netherlands.
Marcus J SchultzDepartment of Intensive Care Medicine, Academic Medical Center, Room G3-228, PO box 22700, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.
Ivo N van SchaikDepartment of Neurology, Academic Medical Center, Amsterdam, the Netherlands.
Janneke HornDepartment of Intensive Care Medicine, Academic Medical Center, Room G3-228, PO box 22700, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.
Academic Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThere are few reports of in vivo muscle strength measurements in animal models of ICU-acquired weakness (ICU-AW). In this study we investigated whether the Escherichia coli (E. coli) septic peritonitis mouse model may serve as an ICU-AW model using in vivo strength measurements and myosin/actin assays, and whether development of ICU-AW is age-dependent in this model.

methodsYoung and old mice were injected intraperitoneally with E. coli and treated with ceftriaxone. Forelimb grip strength was measured at multiple time points, and the myosin/actin ratio in muscle was determined.

resultsE. coli administration was not associated with grip strength decrease, neither in young nor in old mice. In old mice, the myosin/actin ratio was lower in E. coli mice at t = 48 h and higher at t = 72 h compared with controls.

conclusionsThis E. coli septic peritonitis mouse model did not induce decreased grip strength. In its current form, it seems unsuitable as a model for ICU-AW.

Indexed as

AgingIntensive Care UnitsActinsAge FactorsAnimalsAnti-Bacterial AgentsBody WeightCeftriaxoneDisease Models, AnimalEscherichia coliMaleMiceMice, Inbred C57BLMuscle, SkeletalMuscle WeaknessMyosinsActinsAnti-Bacterial AgentsCeftriaxoneMyosinsanimal modelcritical illness myopathycritical illness polyneuropathygrip strengthintensive care unit-acquired weakness

Identifiers

PMID26015329
PMCPMC4744984
OpenAlexW2172935750

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.